{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:23:20Z","timestamp":1794450200547,"version":"4.9.1"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:00:00Z","timestamp":1793145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.pharmthera.2026.109132","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:09:08Z","timestamp":1792537748000},"page":"109132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prospects for adiponectin-based therapeutics in myocardial ischemia reperfusion injury"],"prefix":"10.1016","volume":"289","author":[{"given":"M. Cecilia","family":"Bahit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Michael","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry H.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp E.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2026.109132_bb0005","first-page":"13","article-title":"Cardiac ischaemia-reperfusion injury: Pathophysiology, therapeutic targets and future interventions","author":"Alsadder","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/174341","article-title":"Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells","volume":"2010","author":"Anfossi","year":"2010","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0015","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jcjd.2017.12.002","article-title":"The effect of omega-3 on circulating adiponectin in adults with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials","volume":"42","author":"Bahreini","year":"2018","journal-title":"Canadian Journal of Diabetes"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115871","article-title":"AdipoRon and ADP355, adiponectin receptor agonists, in Metabolic-associated Fatty Liver Disease (MAFLD) and Nonalcoholic Steatohepatitis (NASH): A systematic review","volume":"218","author":"Barbalho","year":"2023","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112866","article-title":"Extracellular vesicles are carriers of adiponectin with insulin-sensitizing and anti-inflammatory properties","volume":"42","author":"Blandin","year":"2023","journal-title":"Cell Reports"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201901253","article-title":"Caffeine upregulates hepatic sex hormone-binding globulin production by increasing adiponectin through AKT\/FOXO1 pathway in white adipose tissue","volume":"64","author":"Brianso-Llort","year":"2020","journal-title":"Molecular Nutrition & Food Research"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/heartjnl-2015-307855","article-title":"Reducing myocardial infarct size: challenges and future opportunities","volume":"102","author":"Bulluck","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0040","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1161\/CIRCULATIONAHA.116.022603","article-title":"Comparative prognostic utility of indexes of microvascular function alone or in combination in patients with an acute ST-segment-elevation myocardial infarction","volume":"134","author":"Carrick","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0045","first-page":"41","article-title":"Adiponectin in neuroinflammation and parkinson's disease: A macromolecular and therapeutic perspective","author":"Chauhan","year":"2026","journal-title":"Metabolic Brain Disease"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0050","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/jcsm.13257","article-title":"Physical exercise attenuates age-related muscle atrophy and exhibits anti-ageing effects via the adiponectin receptor 1 signalling","volume":"14","author":"Chen","year":"2023","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beem.2013.06.006","article-title":"Signaling mechanisms underlying the insulin-sensitizing effects of adiponectin","volume":"28","author":"Cheng","year":"2014","journal-title":"Best Practice & Research. Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116119","article-title":"Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF)","volume":"171","author":"Cho","year":"2024","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70229","article-title":"Lipidomic analysis of plasma extracellular vesicles from adiponectin deficient mice or metabolic syndrome patients reveals pro-oxidative and pro-inflammatory lipid signatures correlating with metabolic dysfunction","volume":"15","author":"Cho","year":"2026","journal-title":"Journal of Extracellular Vesicles"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0070","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMoa1505489","article-title":"Cyclosporine before PCI in patients with acute myocardial infarction","volume":"373","author":"Cung","year":"2015","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0075","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/joic.12485","article-title":"Effects of endovascular cooling on infarct size in ST-segment elevation myocardial infarction: A patient-level pooled analysis from randomized trials","volume":"31","author":"Dae","year":"2018","journal-title":"Journal of Interventional Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0080","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1002\/jcp.30240","article-title":"Iron overload reduces adiponectin receptor expression via a ROS\/FOXO1-dependent mechanism leading to adiponectin resistance in skeletal muscle cells","volume":"236","author":"Dahyaleh","year":"2021","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114800","article-title":"Discovery of novel AdipoRon analogues as potent anti-inflammatory agents against nonalcoholic steatohepatitis","volume":"244","author":"Dai","year":"2022","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0090","article-title":"Adiponectin paradox in coronary artery bypass graft patients: A comparative analysis of pericardial fluid and plasma levels","volume":"17","author":"Dikme","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3945\/jn.115.222414","article-title":"Green tea extract and catechol-o-methyltransferase genotype modify fasting serum insulin and plasma adiponectin concentrations in a randomized controlled trial of overweight and obese postmenopausal women","volume":"146","author":"Dostal","year":"2016","journal-title":"The Journal of Nutrition"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0100","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1253\/circj.CJ-09-0338","article-title":"Why do we still not have cardioprotective drugs?","volume":"73","author":"Downey","year":"2009","journal-title":"Circulation Journal"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0105","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.14336\/AD.2024.0162","article-title":"Adiponectin mRNA conjugated with lipid nanoparticles specifically targets the pathogenesis of type 2 diabetes","volume":"16","author":"El-Araby","year":"2024","journal-title":"Aging and Disease"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0110","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jacc.2013.12.027","volume":"63","author":"Erlinge","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0115","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0006-291X(03)00090-1","article-title":"Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes","volume":"301","author":"Fasshauer","year":"2003","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0120","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jacc.2018.03.545","article-title":"Coronary microvascular dysfunction: Assessment of both structure and function","volume":"72","author":"Ford","year":"2018","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0125","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1055\/a-1239-4349","article-title":"Insights into the controversial aspects of adiponectin in cardiometabolic disorders","volume":"52","author":"Francischetti","year":"2020","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0130","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1161\/STROKEAHA.119.026280","article-title":"Intensive statin therapy compromises the adiponectin-AdipoR pathway in the human monocyte-macrophage lineage","volume":"50","author":"Gasbarrino","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/endrev\/bnae021","article-title":"Adiponectin and adiponectin receptors in atherosclerosis","volume":"46","author":"Gianopoulos","year":"2025","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0140","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/cvr\/cvn017","article-title":"Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide","volume":"78","author":"Gonon","year":"2008","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0145","first-page":"10","article-title":"A stem cell based in vitro model of NAFLD enables the analysis of patient specific individual metabolic adaptations in response to a high fat diet and AdipoRon interference","author":"Graffmann","year":"2021","journal-title":"Biology Open"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0150","doi-asserted-by":"crossref","first-page":"26129","DOI":"10.31083\/FBL26129","article-title":"Physiological activities of adiponectin provide therapeutic opportunities in sepsis","volume":"30","author":"Grewal","year":"2025","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154393","article-title":"Adiponectin's mechanisms in high-density lipoprotein biogenesis and cholesterol efflux","volume":"113","author":"Hafiane","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.153953","article-title":"The role of adiponectin in cholesterol efflux and HDL biogenesis and metabolism","volume":"100","author":"Hafiane","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0165","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2337\/db08-1750","article-title":"Systemic fate of the adipocyte-derived factor adiponectin","volume":"58","author":"Halberg","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0170","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jacc.2006.08.061","article-title":"Adiponectin and cardiovascular disease: response to therapeutic interventions","volume":"49","author":"Han","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0175","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00395-016-0588-8","article-title":"Ischaemic conditioning and targeting reperfusion injury: A 30 year voyage of discovery","volume":"111","author":"Hausenloy","year":"2016","journal-title":"Basic Research in Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0180","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1413534","article-title":"Remote ischemic preconditioning and outcomes of cardiac surgery","volume":"373","author":"Hausenloy","year":"2015","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0185","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cvr\/cvx049","article-title":"Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart","volume":"113","author":"Hausenloy","year":"2017","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0190","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(19)32039-2","article-title":"Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2\/ERIC-PPCI): A single-blind randomised controlled trial","volume":"394","author":"Hausenloy","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0195","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: a neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0200","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s12020-015-0741-4","article-title":"The multimerization and secretion of adiponectin are regulated by TNF-alpha","volume":"51","author":"He","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0205","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jcin.2009.08.012","article-title":"The ideal reperfusion strategy for the ST-segment elevation myocardial infarction patient with expected delay to percutaneous coronary intervention: Paradise lost or paradise renamed?","volume":"2","author":"Henry","year":"2009","journal-title":"JACC. Cardiovascular Interventions"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0210","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.117.310820","article-title":"Critical issues for the translation of cardioprotection","volume":"120","author":"Heusch","year":"2017","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0215","doi-asserted-by":"crossref","DOI":"10.1177\/10742484231179613","article-title":"Cardioprotection and its translation: A need for new paradigms? Or for new pragmatism? An opinionated retro- and perspective","volume":"28","author":"Heusch","year":"2023","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0220","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13760","article-title":"The adiponectin-derived peptide ALY688 protects against the development of metabolic dysfunction-associated steatohepatitis","volume":"17","author":"Huang","year":"2024","journal-title":"Clinical and Translational Science"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0225","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jacc.2019.05.024","article-title":"Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC scientific expert panel","volume":"74","author":"Ibanez","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111537","article-title":"MicroRNA-378 regulates adiponectin expression in adipose tissue: a new plausible mechanism","volume":"9","author":"Ishida","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0240","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14328","article-title":"Adiponectin as a biomarker in liver cirrhosis-A systematic review and meta-analysis","volume":"55","author":"Ismaiel","year":"2025","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0245","first-page":"13","article-title":"The influence of nutrition on adiponectin-A narrative review","author":"Janiszewska","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0250","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018097","article-title":"AdipoRon attenuates inflammation and impairment of cardiac function associated with cardiopulmonary bypass-induced systemic inflammatory response syndrome","volume":"10","author":"Jenke","year":"2021","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0255","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1547-5069.1987.tb00608.x","article-title":"Policy and research in end-stage renal disease","volume":"19","author":"Jones","year":"1987","journal-title":"Image \u2013 the Journal of Nursing Scholarship"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155698","article-title":"The interplay between statins and adipokines. Is this another explanation of statins' 'pleiotropic' effects?","volume":"148","author":"Kadoglou","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0265","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"Kadowaki","year":"2006","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0270","first-page":"15","article-title":"Unravelling the adiponectin hallmark and exploring the therapeutic potential of its receptor agonists in cancer metabolic reprogramming","author":"Kafeel","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0275","first-page":"14","article-title":"An explanation for the adiponectin paradox","author":"Kalkman","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0280","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCULATIONAHA.118.038269","article-title":"Unloading the left ventricle before reperfusion in patients with anterior ST-segment-elevation myocardial infarction","volume":"139","author":"Kapur","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0285","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCULATIONAHA.112.000029","article-title":"Mechanically unloading the left ventricle before coronary reperfusion reduces left ventricular wall stress and myocardial infarct size","volume":"128","author":"Kapur","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0290","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MOL.0000000000000431","article-title":"Adiponectin, lipids and atherosclerosis","volume":"28","author":"Katsiki","year":"2017","journal-title":"Current Opinion in Lipidology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0295","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11892-025-01610-5","article-title":"The cardioprotective effects of adiponectin in diabetes","volume":"25","author":"Kazemi","year":"2025","journal-title":"Current Diabetes Reports"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0300","first-page":"25","article-title":"Mesenchymal stem cell-derived exosomes attenuate hepatic steatosis and insulin resistance in diet-induced obese mice by activating the FGF21-adiponectin axis","author":"Kim","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0305","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJM200011163432003","article-title":"The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction","volume":"343","author":"Kim","year":"2000","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0310","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jacbts.2021.07.011","article-title":"Update on cardioprotective strategies for STEMI: Focus on supersaturated oxygen delivery","volume":"6","author":"Kloner","year":"2021","journal-title":"JACC Basic Translation Science"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0315","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCINTERVENTIONS.109.872044","article-title":"Impact of a single intracoronary administration of adiponectin on myocardial ischemia\/reperfusion injury in a pig model","volume":"3","author":"Kondo","year":"2010","journal-title":"Circulation. Cardiovascular Interventions"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0320","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014454","article-title":"Prognostic value of cardiac magnetic resonance imaging in patients with a working diagnosis of MINOCA-An outcome study with up to 10 years of follow-up","volume":"16","author":"Konst","year":"2023","journal-title":"Circulation. Cardiovascular Imaging"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0325","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12968-020-00607-1","article-title":"Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update","volume":"22","author":"Kramer","year":"2020","journal-title":"Journal of Cardiovascular Magnetic Resonance"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0330","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2013.10.014","article-title":"MicroRNA-150 inhibits expression of adiponectin receptor 2 and is a potential therapeutic target in patients with chronic heart failure","volume":"33","author":"Kreth","year":"2014","journal-title":"The Journal of Heart and Lung Transplantation"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0335","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrcardio.2012.156","article-title":"Timely and optimal treatment of patients with STEMI","volume":"10","author":"Lassen","year":"2013","journal-title":"Nature Reviews. Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0340","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00210-024-03362-7","article-title":"Unraveling the rationale and conducting a comprehensive assessment of AdipoRon (adiponectin receptor agonist) as a candidate drug for diabetic nephropathy and cardiomyopathy prevention and intervention-a systematic review","volume":"398","author":"Laurindo","year":"2025","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115732","article-title":"Exploring adipose tissue-derived extracellular vesicles in inter-organ crosstalk: Implications for metabolic regulation and adipose tissue function","volume":"44","author":"Le Lay","year":"2025","journal-title":"Cell Reports"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0350","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/ehjci\/jeaf250","article-title":"Associations and prognostic implications of myocardial tissue injury stages in ST-elevation myocardial infarction using the Canadian Cardiovascular Society classification","volume":"27","author":"Lechner","year":"2026","journal-title":"European Heart Journal Cardiovascular Imaging"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102823","article-title":"The therapeutic potential of adiponectin and extracellular vesicles for promoting improved healthspan","volume":"111","author":"Lei","year":"2025","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0360","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1021\/acsengineeringau.5c00035","article-title":"Process and formulation parameters governing polymeric microparticle formation via Sequential NanoPrecipitation (SNaP)","volume":"5","author":"Lewis","year":"2025","journal-title":"ACS Engineering Au"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0365","first-page":"13","article-title":"In-house microcomputer software package for management of histopathology reports","volume":"14","author":"Lim","year":"1992","journal-title":"The Malaysian Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0370","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.2337\/db07-0127","article-title":"Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic\/knockout mice","volume":"56","author":"Lin","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0375","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1093\/eurheartj\/ehu177","article-title":"Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: Results of the PROTECTION AMI Randomized Controlled Trial","volume":"35","author":"Lincoff","year":"2014","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0380","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3389\/fendo.2019.00842","article-title":"Examining the potential of developing and implementing use of adiponectin-targeted therapeutics for metabolic and cardiovascular diseases","volume":"10","author":"Liu","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.pharmthera.2026.109132_bb0385","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/eurheartj\/ehr309","article-title":"Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction","volume":"33","author":"Lonborg","year":"2012","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111890","article-title":"A novel blood-based bioassay to monitor adiponectin signaling","volume":"132","author":"Lone","year":"2024","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0395","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10741-012-9330-2","article-title":"Mitochondria in heart failure: The emerging role of mitochondrial dynamics","volume":"18","author":"Marin-Garcia","year":"2013","journal-title":"Heart Failure Reviews"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0400","first-page":"11","article-title":"Recent progress in the oral delivery of therapeutic peptides and proteins: Overview of pharmaceutical strategies to overcome absorption hurdles","volume":"14","author":"Mehrotra","year":"2024","journal-title":"Advanced Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0405","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa1413579","article-title":"A multicenter trial of remote ischemic preconditioning for heart surgery","volume":"373","author":"Meybohm","year":"2015","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0410","first-page":"14","article-title":"State of the art of primary PCI: Present and future","author":"Mignatti","year":"2025","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0415","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.numecd.2023.01.014","article-title":"A case-cohort study of the association between adiponectin and mortality in EPIC-Heidelberg: NT-proBNP may explain the adiponectin paradox","volume":"33","author":"Mukama","year":"2023","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0420","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db25-0405","article-title":"ALY688 attenuates iron-induced ER stress and insulin resistance via activation of ER-Phagy","volume":"74","author":"Nguyen","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0425","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/eurheartj\/ehv484","article-title":"Coronary microvascular obstruction in acute myocardial infarction","volume":"37","author":"Niccoli","year":"2016","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0430","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1111\/dom.16542","article-title":"AdipoRon attenuates steatosis, inflammation and fibrosis in murine diet-induced NASH via inhibiting ER stress","volume":"27","author":"Nie","year":"2025","journal-title":"Diabetes, Obesity & Metabolism"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0435","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/658913","article-title":"New insight into adiponectin role in obesity and obesity-related diseases","volume":"2014","author":"Nigro","year":"2014","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0440","first-page":"e362","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0445","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1507\/endocrj.EJ18-0310","article-title":"Structure and function analysis of adiponectin receptors toward development of novel antidiabetic agents promoting healthy longevity","volume":"65","author":"Okada-Iwabu","year":"2018","journal-title":"Endocrine Journal"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0450","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s13340-019-00409-6","article-title":"Drug development research for novel adiponectin receptor-targeted antidiabetic drugs contributing to healthy longevity","volume":"10","author":"Okada-Iwabu","year":"2019","journal-title":"Diabetology International"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0455","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature12656","article-title":"A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity","volume":"503","author":"Okada-Iwabu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0460","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1038\/s41598-020-61148-2","article-title":"Melinjo seed extract increases adiponectin multimerization in physiological and pathological conditions","volume":"10","author":"Oniki","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0465","article-title":"A comparison of adiponectin-deficient mice reveals the fundamental role of intracellular adiponectin","author":"Onodera","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0470","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fendo.2019.00539","article-title":"Potential adiponectin receptor response modifier therapeutics","volume":"10","author":"Otvos","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.pharmthera.2026.109132_bb0475","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1472-6750-11-90","article-title":"Design and development of a peptide-based adiponectin receptor agonist for cancer treatment","volume":"11","author":"Otvos","year":"2011","journal-title":"BMC Biotechnology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0480","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/eje.1.01978","article-title":"The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals","volume":"153","author":"Peake","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0485","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12986-016-0138-2","article-title":"Interactions of exercise training and high-fat diet on adiponectin forms and muscle receptors in mice","volume":"13","author":"Pierard","year":"2016","journal-title":"Nutrition & Metabolism (London)"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0490","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.metabol.2019.05.001","article-title":"Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and\/or leptin replacement","volume":"96","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0495","series-title":"Biochemistry, adiponectin","author":"Ramakrishnan","year":"2026"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0500","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.nutres.2020.11.002","article-title":"Systematic review of marine-derived omega-3 fatty acid supplementation effects on leptin, adiponectin, and the leptin-to-adiponectin ratio","volume":"85","author":"Rausch","year":"2021","journal-title":"Nutrition Research"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0505","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0196-0644(89)80590-6","article-title":"Accidental intra-arterial injection of epinephrine treated with phentolamine","volume":"18","author":"Roberts","year":"1989","journal-title":"Annals of Emergency Medicine"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0510","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.jacc.2005.02.061","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II)","volume":"45","author":"Ross","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0515","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1086\/679608","article-title":"Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure (2013 Grover Conference Series)","volume":"5","author":"Sankaralingam","year":"2015","journal-title":"Pulmonary Circulation"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0520","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2147\/DMSO.S387744","article-title":"Adiponectin paradox more evident in non-obese than in obese patients with diabetic microvascular complications","volume":"16","author":"Satoh","year":"2023","journal-title":"Diabetes, Metabolic Syndrome and Obesity"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0525","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10741-016-9578-z","article-title":"The evolving role of adiponectin as an additive biomarker in HFrEF","volume":"21","author":"Sente","year":"2016","journal-title":"Heart Failure Reviews"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108008","article-title":"The adiponectin signalling pathway - A therapeutic target for the cardiac complications of type 2 diabetes?","volume":"232","author":"Sharma","year":"2022","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0535","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.yjmcc.2007.03.808","article-title":"Adiponectin protects against the development of systolic dysfunction following myocardial infarction","volume":"42","author":"Shibata","year":"2007","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0540","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1295","article-title":"Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms","volume":"11","author":"Shibata","year":"2005","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0545","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.yjmcc.2010.02.021","article-title":"Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response","volume":"49","author":"Shimano","year":"2010","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0550","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12872-016-0464-3","article-title":"Effect of erythropoietin in patients with acute myocardial infarction: Five-year results of the REVIVAL-3 trial","volume":"17","author":"Steppich","year":"2017","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0555","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006568","article-title":"Coronary microvascular obstruction: Key factor in the prognosis of ST-segment-elevation myocardial infarction","volume":"10","author":"Stiermaier","year":"2017","journal-title":"Circulation. Cardiovascular Imaging"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0560","doi-asserted-by":"crossref","first-page":"C151","DOI":"10.1152\/ajpcell.00603.2020","article-title":"ALY688 elicits adiponectin-mimetic signaling and improves insulin action in skeletal muscle cells","volume":"322","author":"Sung","year":"2022","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0565","first-page":"24","article-title":"Age-related adiponectin resistance in human skeletal muscle dysfunction: In vivo and in vitro evidence","author":"Surina","year":"2026","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0570","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1002\/jcp.27597","article-title":"Mitochondrial quality control in cardiac cells: Mechanisms and role in cardiac cell injury and disease","volume":"234","author":"Tahrir","year":"2019","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0575","doi-asserted-by":"crossref","first-page":"40","DOI":"10.12997\/jla.2025.14.1.40","article-title":"Cardioprotective effects of adiponectin-stimulated autophagy","volume":"14","author":"Tam","year":"2025","journal-title":"Journal of Lipid and Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0580","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s42003-020-01160-4","article-title":"Human adiponectin receptor AdipoR1 assumes closed and open structures","volume":"3","author":"Tanabe","year":"2020","journal-title":"Communications Biology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0585","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nature14301","article-title":"Crystal structures of the human adiponectin receptors","volume":"520","author":"Tanabe","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0590","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10969-014-9192-z","article-title":"Expression, purification, crystallization, and preliminary X-ray crystallographic studies of the human adiponectin receptors, AdipoR1 and AdipoR2","volume":"16","author":"Tanabe","year":"2015","journal-title":"Journal of Structural and Functional Genomics"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0595","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202505837","article-title":"Extracellular vesicles modulation by an adiponectin receptor agonist provides cardioprotection for myocardial ischemic injury","volume":"15","author":"Tang","year":"2026","journal-title":"Advanced Healthcare Materials"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110994","article-title":"Development of a non-invasive bioassay for adiponectin target engagement in mice","volume":"27","author":"Tang","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0605","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCRESAHA.109.211797","article-title":"Adiponectin: An indispensable molecule in rosiglitazone cardioprotection following myocardial infarction","volume":"106","author":"Tao","year":"2010","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113964","article-title":"Human Fc C(H)2 domain modifies cholix transcytosis pathway to facilitate efficient oral therapeutic protein delivery","volume":"385","author":"Taverner","year":"2025","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2025.104164","article-title":"Plasma adiponectin levels are associated with habitual dietary polyphenol intake in individuals at high cardiometabolic risk: a cross-sectional study","volume":"35","author":"Testa","year":"2025","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0620","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.atherosclerosis.2011.12.014","article-title":"Adiponectin-AdipoR1\/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses","volume":"221","author":"Tian","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0625","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/ggi.12306","article-title":"Acute adiponectin delivery is cardioprotective in the aged female rat heart","volume":"15","author":"Tomicek","year":"2015","journal-title":"Geriatrics & Gerontology International"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0630","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-3-319-55330-6_15","article-title":"Mitochondria in structural and functional cardiac remodeling","volume":"982","author":"Torrealba","year":"2017","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0635","article-title":"Zalunfiban at first medical contact for ST-elevation myocardial infarction","volume":"5","author":"Van't Hof","year":"2026","journal-title":"NEJM Evidence"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0640","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nature21714","article-title":"Structural insights into adiponectin receptors suggest ceramidase activity","volume":"544","author":"Vasiliauskaite-Brooks","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0645","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1586\/14779072.5.6.1123","article-title":"Metabolic therapy for the treatment of ischemic heart disease: reality and expectations","volume":"5","author":"Wang","year":"2007","journal-title":"Expert Review of Cardiovascular Therapy"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0650","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jmcb\/mjw011","article-title":"Adiponectin, the past two decades","volume":"8","author":"Wang","year":"2016","journal-title":"Journal of Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0655","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1463-1326.2005.00510.x","article-title":"Adiponectin--a key adipokine in the metabolic syndrome","volume":"8","author":"Whitehead","year":"2006","journal-title":"Diabetes, Obesity & Metabolism"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0660","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/cvr\/cvy093","article-title":"Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction","volume":"114","author":"Xia","year":"2018","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0665","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.beem.2013.09.003","article-title":"Adiponectin receptors: a review of their structure, function and how they work","volume":"28","author":"Yamauchi","year":"2014","journal-title":"Best Practice & Research. Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0670","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12944-024-02028-w","article-title":"Adiponectin protects against myocardial ischemia-reperfusion injury: a systematic review and meta-analysis of preclinical animal studies","volume":"23","author":"Yue","year":"2024","journal-title":"Lipids in Health and Disease"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0675","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/CIRCHEARTFAILURE.112.000228","article-title":"Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy","volume":"6","author":"Zhang","year":"2013","journal-title":"Circulation. Heart Failure"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0680","doi-asserted-by":"crossref","first-page":"E275","DOI":"10.1152\/ajpendo.00577.2014","article-title":"AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings","volume":"309","author":"Zhang","year":"2015","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0685","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbrc.2020.09.035","article-title":"Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress","volume":"533","author":"Zhao","year":"2020","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0690","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCRESAHA.120.314458","article-title":"Adiponectin, leptin and cardiovascular disorders","volume":"128","author":"Zhao","year":"2021","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0695","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1161\/CIRCRESAHA.121.319976","article-title":"Targeting adiponectin receptor 1 phosphorylation against ischemic heart failure","volume":"131","author":"Zhu","year":"2022","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2026.109132_bb0700","doi-asserted-by":"crossref","first-page":"4253457","DOI":"10.1155\/2020\/4253457","article-title":"Adiponectin facilitates postconditioning cardioprotection through both AMPK-dependent nuclear and AMPK-independent mitochondrial STAT3 activation","volume":"2020","author":"Zhu","year":"2020","journal-title":"Oxidative Medicine and Cellular Longevity"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826001592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826001592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:13:04Z","timestamp":1794449584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725826001592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":140,"alternative-id":["S0163725826001592"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109132","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospects for adiponectin-based therapeutics in myocardial ischemia reperfusion injury","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109132"}}